Aethlon Medical Inc (AEMD)vsStryker Corporation (SYK)
AEMD
Aethlon Medical Inc
$5.55
+9.47%
HEALTHCARE · Cap: $8.26M
SYK
Stryker Corporation
$304.00
+0.86%
HEALTHCARE · Cap: $113.02B
Smart Verdict
WallStSmart Research — data-driven comparison
Stryker Corporation generates 4499238% more annual revenue ($25.84B vs $574,240). SYK leads profitability with a 14.4% profit margin vs 0.0%. SYK earns a higher WallStSmart Score of 67/100 (B-).
AEMD
Hold39
out of 100
Grade: F
SYK
Strong Buy67
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-69.9%
Fair Value
$1.23
Current Price
$5.55
$4.32 premium
Margin of Safety
-33.2%
Fair Value
$229.90
Current Price
$304.00
$74.10 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 4278.0% year-over-year
Conservative balance sheet, low leverage
Large-cap with strong market position
Strong operational efficiency at 27.0%
Earnings expanding 44.1% YoY
Generating 1.1B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Operating margin of 0.0%
Premium valuation, high expectations priced in
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : AEMD
The strongest argument for AEMD centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 4278.0% demonstrates continued momentum.
Bull Case : SYK
The strongest argument for SYK centers on Market Cap, Operating Margin, EPS Growth. PEG of 1.29 suggests the stock is reasonably priced for its growth.
Bear Case : AEMD
The primary concerns for AEMD are EPS Growth, Market Cap, Profit Margin.
Bear Case : SYK
The primary concerns for SYK are P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
AEMD profiles as a hypergrowth stock while SYK is a value play — different risk/reward profiles.
AEMD carries more volatility with a beta of 1.21 — expect wider price swings.
AEMD is growing revenue faster at 4278.0% — sustainability is the question.
SYK generates stronger free cash flow (1.1B), providing more financial flexibility.
Bottom Line
SYK scores higher overall (67/100 vs 39/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Aethlon Medical Inc
HEALTHCARE · MEDICAL DEVICES · USA
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life- and organ-threatening diseases in the United States. The company is headquartered in San Diego, California.
Stryker Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?